Market Closed -
Japan Exchange
02:00:00 2024-05-10 am EDT
5-day change
1st Jan Change
1,535
JPY
-5.89%
-5.42%
-6.66%
Sankyo Co., Ltd.'s Equity Buyback announced on November 7, 2023, has closed with 50,000,000 shares, representing 19.32% for ¥68,767.93 million.
The company closed its plan on March 22, 2024.
Sankyo Co., Ltd. sDividend for the Year Ending March 31, 2024, Payable on June 28, 2024; Provides Earnings Guidance for the Year Ended March 31, 2025
May. 09
CI
Sankyo Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2025
May. 09
CI
AstraZeneca makes progress with Truqap and Enhertu cancer treatments
Apr. 29
AN
AstraZeneca upbeat as cancer drugs underpin sales growth
Apr. 25
AN
AstraZeneca hails neurological data for Ultomiris, Soliris
Apr. 08
AN
AstraZeneca's, Daiichi's Enhertu receives US FDA approval
Apr. 08
AN
AstraZeneca, Daiichi make US progress with licence approvals
Apr. 03
AN
AstraZeneca and Daiichi make US progress with latest licence approvals
Apr. 02
AN
Sankyo Exhausts Buyback Program After Repurchasing 50 Million Shares for 68.77 Billion Yen
Mar. 26
MT
Tranche Update on Sankyo Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.
Mar. 25
CI
Sankyo Co., Ltd.'s Equity Buyback announced on November 7, 2023, has closed with 50,000,000 shares, representing 19.32% for ¥68,767.93 million.
Mar. 21
CI
AstraZeneca's breast cancer treatment blocked for NHS use in England
Mar. 05
AN
AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment
Mar. 04
AN
Nikkei extends record rally on pharma boost
Feb. 25
RE
Nikkei hits record high as index heavyweights advance
Feb. 25
RE
AstraZeneca completes USD1.1 billion acquisition of Icosavax
Feb. 19
AN
AstraZeneca celebrates Tagrisso approval and new data
Feb. 19
AN
Sankyo Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Grow
Feb. 07
MT
Sankyo Co., Ltd. Reports Earnings Results for the Nine Months Ended December 31, 2023
Feb. 07
CI
SANKYO Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024
Feb. 07
CI
SANKYO Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024
Feb. 07
CI
Japan's Nikkei slips after Fed chair signals delay in rate cut
Jan. 31
RE
AstraZeneca, Daiichi's Enhertu granted priority review in US
Jan. 29
AN
Sankyo Acquires Own Shares for 5.54 Billion Yen in December 2023
Jan. 08
MT
Tranche Update on Sankyo Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.
Jan. 05
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Sankyo Co Ltd is a Japan-based company mainly engaged in the pachinko machine related business, pachislot machine related business, and replenishment equipment related business. The Company operates through three business segments. The Pachinko Machine-related Business segment is engaged in the manufacture and sale of pachinko machines and gauge boards for pachinko machines, the sale of related parts, and acquisition of royalties income related to pachinko machines. The Pachislot Machine-related Business segment is engaged in the manufacture and sale of pachislot machines, the sale of related parts, and acquisition of royalties income related to pachislot machines. The Supply Equipment-related Business segment is engaged in the sale of pachinko/pachislot supply equipment, card system equipment, hall equipment peripheral equipment. It also provides mobile content services, real estate rental, sales of general molded parts.
More about the company
Last Close Price
1,535
JPY
Average target price
1,928
JPY
Spread / Average Target
+25.57%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1